CEREBROPROTECTION BY GERMANIUM COORDINATION COMPOUNDS IN EXPERIMENTAL ACUTE GLOBAL BRAIN ISCHEMIA
Background. Stroke is among the leading causes of death and disability worldwide with rising incidence among young people today. This is the third most common cause of disability-adjusted life-years worldwide
Objective. The present study evaluated the cerebroprotective action of coordination compounds of germanium with underlying global cerebral ischemia in rats.
Methods. Global cerebral infarction was induced by bilateral common carotid artery occlusion. For primary screening we used numerous bis(citrate) germanates (stannates) compounds, which contained different metals: OL1-8, and VITAGERM-1,2,3 and 4. All germanium complexes used were injected intraperitoneally (1 % aqueous solution at a dose of 50 and 100 mg/kg in 35 min after bilateral common carotid artery occlusion). Piracetam was used as a reference drug. Criteria of cerebroprotection efficacy: survival of rats (%), ET50 (median effective time), observational Irwin’s test.
Results. Almost all bis(citrate) germanates (stannates), which contained different metals, possessed anti-ischemic activity of different intensity. The exceptions were cobalt-containing OL-6 and OL-2 compounds. The most significant efficacy of all investigated indices (which exceeded even reference drug) was evidenced for VITAGERM-1 – a coordination compound of germanium, diethylenetriaminepentaacetic acid and lithium.
Conclusions. Results of our experiments are the substitution for further more profound pharmacological investigation of VITAGERM-1 for stroke cerebroprotection and its implementation into clinics.
World Health organization WHO updates fact sheet on Top 10 causes of Death. 27 Jan 2017.
Zozulia IS. Epidemiology of cerebrovascular diseases in Ukraine. Ukrainian Medical Journal. 2011;85(5):38–41 [In Ukrainian].
Smajlovic D Strokes in young adults epidemiology and prevention. Vascular Health and Risk Management. 2015;11:157–164. doi.org/10.2147/VHRM.S53203. Feb 2015.
Musuka TD Wilton SB Traboulsi M Hill MD Diagnosis and management of acute ischemic stroke: speed is critical. CMAJ : Canadian Medical Association Journal. 2015;187(12):887–893. doi.org/10.1503/cmaj.140355. Aug 2015.
Sas A, Horvath L, Olah C, Valikovics A. A. Review of Neuroinflammatory Mechanisms in Ischemic Stroke: Background and Therapeutic Approaches. InMechanisms of Neuroinflammation. 2017. InTech.
Lukianchuk VD, Zhytina IO, Seifullina II, Martsinko OE, Pesaroglo OG. Screening and com- parative characteristic of anti ischemic e cacy of coordination compounds of germanium in acute cerebrovascular insuficiency Pharmacology and Drug Toxicology [In Ukrainian].
Lukianchuk VD, Krylova EV, Seifullina II, Tkachenko VN. Screening of potential cerebro- protectors among newly synthesized coordination compounds of germanium with complexions of hydroxycarboxylic acids in the model of global cerebral ischemia. GO Mozhaev Journal of Emergency Medicine. 2008;9(4):123–126 [In Russian].
Gad SC. Drug safety evaluation. John Wiley & Sons. Accessed 7 Nov 2016.
Stefanov OV. Preclinical study of drugs: methodical instructions. K: Avicenna. 2001:292–306.
Chadova LV, Seifulina II, Tkachenko VM. Screening and comparative characteristic of antiischemic drugs among coordination compounds of germanium with bioligands in acute cerebrovascular insufficiency. Odesa Medical Journal. 2005;6:19–22 [In Ukrainian].
Lukianchuk VD, Seifullina II, Litvinenko DF, Martsinko OE. Pharmacodynamics of organic and coordination compounds of germanium – modern state of art Pharmacology and Drug Toxicology. 2016;1:3–13 [In Ukrainian].
Shutka AO, Kravets DS, Lukianchuk VD. Mathematical-pharmacological analysis of dose regimen of new antihypoxant OK Ukrainian Journal of Cliniacll and Laboratory Medicine. 2010;5(4):115–9.
Canazza A, Minati L, Boffano C, Parati E, Binks S. Experimental models of brain ischemia a review of techniques, magnetic resonance imaging, and investigational cell-based therapies. Front Neurol. Frontiers Media SA. 2014;5:19.
Durukan A, Tatlisumak T. Acute ischemic stroke overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacology Biochemistry and Behavior. 2007;87(1):179–97.
Fluri F, Schuhmann MK, Kleinschnitz C. Animal models of ischemic stroke and their application in clinical research. Drug design, development and therapy. 2015;9:3445.
Winblad B Piracetam a review of phar macological properties and clinical uses. CNS Drug Rev. 2005;11(2):169–82.
Navarro-Mabarak C, Camacho-Carranza R, Espinosa-Aguirre JJ. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases. Drug Metabolism Reviews. 2018;50(2):95–108.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).